Last reviewed · How we verify
NCT05005377
Peri-Implant Soft and Hard Tissue Stability Following Socket Preservation
NA trial testing Socket Preservation with Platelet-Rich Fibrin in Alveolar Ridge Augmentation in 48 participants. Completed in 1 March 2020.
1 December 2018
Quick facts
| Lead sponsor | Tehran University of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 1 December 2016 |
| Primary completion | 1 December 2018 |
| Estimated completion | 1 March 2020 |
Drugs / interventions tested
- Socket Preservation with Platelet-Rich Fibrin
- Socket Preservation with Freeze-Dried Bone Allograft
Conditions studied
- Alveolar Ridge Augmentation — all drugs for Alveolar Ridge Augmentation →
- Bone Transplantation — all drugs for Bone Transplantation →
Sponsor
Tehran University of Medical Sciences
Who can join
18 and older, any sex, with Alveolar Ridge Augmentation or Bone Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The viability of Platelet Rich Fibrin (PRF) on enhancement of osseous and associated tissue healing has been substantiated well in literature. This study aimed to assess peri-implant soft and hard tissue changes after prosthetic loading of implants following socket preservation with platelet-rich fibrin (PRF) and freeze-dried bone allograft (FDBA) in a 12-month period. This Study evaluated 48 patients who were randomly divided into two groups for anterior ridge preservation with PRF and FDBA. At 12 months after implant placement and prosthetic delivery, bone loss was evaluated radiographically while soft tissue changes were evaluated by measuring gingival recession, papilla index, and bleeding on probing (BOP). The differences between the PRF and FDBA groups were analyzed using Fisher's exact test and student's t-test (P\<0.05).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of platelet-rich fibrin (PRF) versus freeze-dried bone allograft (FDBA) used in alveolar ridge preservation on the peri-implant soft and hard tissues: a randomized clinical trial.
Azangookhiavi H, Habibzadeh S, Zahmatkesh H, Mellati E, et al · · 2024 · cited 6× · PMID 38877446 · DOI 10.1186/s12903-024-04478-1
Verify or expand the search:
- PubMed search for NCT05005377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alveolar Ridge Augmentation
Currently open trials in the same condition.
- NCT06783660 — PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction · NA · recruiting
Other Tehran University of Medical Sciences trials
Trials by the same sponsor.
- NCT07305883 — Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain · Phase 3 · not yet recruiting
- NCT06876194 — The Effect of Music on the Sedation Quality Among Children in the Emergency Department. · Phase 3 · completed
- NCT06721273 — Iodine Supplementation and Fertility Parameters · NA · not yet recruiting
- NCT07014397 — Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth · NA · completed
- NCT06615934 — Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05005377 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tehran University of Medical Sciences
- Last refreshed: 13 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing